Sidse Ehmsen

1.3k total citations · 1 hit paper
20 papers, 759 citations indexed

About

Sidse Ehmsen is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sidse Ehmsen has authored 20 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sidse Ehmsen's work include Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (5 papers) and Breast Cancer Treatment Studies (3 papers). Sidse Ehmsen is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (5 papers) and Breast Cancer Treatment Studies (3 papers). Sidse Ehmsen collaborates with scholars based in Denmark, Sweden and United States. Sidse Ehmsen's co-authors include Henrik J. Ditzel, Mikkel G. Terp, Rikke Leth‐Larsen, Thomas P. Conrads, Brian L. Hood, Martin H. Pedersen, Guisong Wang, Martin Bak, Carla L. Alves and Gokce Oguz and has published in prestigious journals such as Nature Communications, Cancer Cell and Biochemical Journal.

In The Last Decade

Sidse Ehmsen

20 papers receiving 754 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation

2023 148 citations Isabelle Bourget, Pascal Lopez et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sidse Ehmsen Denmark	13	348	311	289	189	182	20	759
Mikkel G. Terp Denmark	19	637 1.8×	342 1.1×	404 1.4×	210 1.1×	270 1.5×	42	1.2k
Sivan Izraely Israel	17	477 1.4×	264 0.8×	419 1.4×	232 1.2×	226 1.2×	24	906
Stefanie Tiede Switzerland	9	536 1.5×	312 1.0×	455 1.6×	115 0.6×	105 0.6×	9	936
Supreet Agarwal United States	10	279 0.8×	153 0.5×	192 0.7×	160 0.8×	82 0.5×	15	539
Yeonjoo Jung South Korea	18	689 2.0×	182 0.6×	241 0.8×	156 0.8×	67 0.4×	26	953
Ryan T. Davis United States	6	591 1.7×	391 1.3×	365 1.3×	80 0.4×	107 0.6×	6	893
April Davis United States	6	617 1.8×	316 1.0×	634 2.2×	97 0.5×	133 0.7×	10	996
Yuanke Liang China	16	488 1.4×	238 0.8×	249 0.9×	127 0.7×	62 0.3×	30	752
Xiao‐En Xu China	20	815 2.3×	647 2.1×	354 1.2×	187 1.0×	117 0.6×	28	1.3k
Vijayalakshmi Kari Germany	19	837 2.4×	218 0.7×	425 1.5×	97 0.5×	98 0.5×	21	1.1k

Countries citing papers authored by Sidse Ehmsen

Since Specialization

Citations

This map shows the geographic impact of Sidse Ehmsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidse Ehmsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidse Ehmsen more than expected).

Fields of papers citing papers by Sidse Ehmsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sidse Ehmsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidse Ehmsen. The network helps show where Sidse Ehmsen may publish in the future.

Co-authorship network of co-authors of Sidse Ehmsen

This figure shows the co-authorship network connecting the top 25 collaborators of Sidse Ehmsen. A scholar is included among the top collaborators of Sidse Ehmsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sidse Ehmsen. Sidse Ehmsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ehmsen, Sidse, Sofie Traynor, N I Nissen, et al.. (2025). RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer. Frontiers in Oncology. 14. 1497093–1497093. 1 indexed citations

Alves, Carla L., Sidse Ehmsen, Thomas Reinert, et al.. (2024). Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4 /6 inhibitor in advanced breast cancer. International Journal of Cancer. 155(12). 2211–2222. 6 indexed citations

Bourget, Isabelle, Pascal Lopez, Julien Cherfils‐Vicini, et al.. (2023). Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation. Cancer Cell. 41(4). 757–775.e10. 148 indexed citations breakdown →

Ma, Shijun, Yue Zhao, L.S. Ong, et al.. (2022). Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nature Communications. 13(1). 4118–4118. 116 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2022). Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer. npj Precision Oncology. 6(1). 68–68. 47 indexed citations

Alves, Carla L., et al.. (2022). Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 23(17). 10053–10053. 6 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2021). Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Communications. 12(1). 5588–5588. 5 indexed citations

Akrap, Nina, Johan Staaf, Carla L. Alves, et al.. (2021). Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer. Breast Cancer Research. 23(1). 26–26. 25 indexed citations

Alves, Carla L., Sidse Ehmsen, Mikkel G. Terp, et al.. (2021). Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Communications. 12(1). 5112–5112. 56 indexed citations

10.

Ewertz, Marianne, Sidse Ehmsen, Trine Lembrecht Jørgensen, et al.. (2021). Udfordringer ved kræftbehandling til ældre. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations

11.

Ehmsen, Sidse, Lasse Jakobsen, Maria Elisabeth Lendorf, et al.. (2021). Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study. Acta Oncologica. 60(7). 859–865. 4 indexed citations

12.

Yi, Bao, Gokce Oguz, Puay Leng Lee, et al.. (2020). EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature Communications. 11(1). 5878–5878. 35 indexed citations

13.

Ehmsen, Sidse & Henrik J. Ditzel. (2020). Signaling pathways essential for triple-negative breast cancer stem-like cells. Stem Cells. 39(2). 133–143. 30 indexed citations

14.

Ehmsen, Sidse, Martin H. Pedersen, Guisong Wang, et al.. (2019). Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome. Cell Reports. 27(13). 3927–3938.e6. 139 indexed citations

15.

Pedersen, Martin H., Brian L. Hood, Sidse Ehmsen, et al.. (2018). CYPOR is a novel and independent prognostic biomarker of recurrence‐free survival in triple‐negative breast cancer patients. International Journal of Cancer. 144(3). 631–640. 20 indexed citations

16.

Kodahl, Annette Raskov, Sidse Ehmsen, Niels Pallisgaard, et al.. (2018). Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer. Molecular Oncology. 12(6). 925–935. 52 indexed citations

17.

Ehmsen, Sidse, Mikkel G. Terp, Richa Batra, et al.. (2017). Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening. Stem Cells. 35(8). 1898–1912. 12 indexed citations

18.

Ehmsen, Sidse, et al.. (2016). S100A14 increases tumorigenesis in triple-negative breast cancer. European Journal of Cancer. 61. S89–S89. 1 indexed citations

19.

Ehmsen, Sidse, et al.. (2015). S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype. International Journal of Cancer. 137(9). 2093–2103. 18 indexed citations

20.

Elle, Ida C., Louise C. B. Olsen, Sidse Ehmsen, et al.. (2011). Tissue- and paralogue-specific functions of acyl-CoA-binding proteins in lipid metabolism in Caenorhabditis elegans. Biochemical Journal. 437(2). 231–241. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact